Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
To enable company to be future-ready by tapping potential in CDMO space
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
Subscribe To Our Newsletter & Stay Updated
